A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies
Status:
Completed
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, safety study. Eligible subjects will be adults with
advanced malignancies. The study includes a pretreatment and treatment phase. The
pretreatment phase consists of screening and baseline periods. The treatment phase consists
of 4-week treatment periods and a follow-up period.